DocGo Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
DocGo Inc. (DCGO) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $13.14 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2025-02-27
- DocGo Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-12-31 was $3.51M.
- DocGo Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-09-30 was $2.87M, a 13.83% decline year-over-year.
- DocGo Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-06-30 was $2.42M.
- DocGo Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-03-31 was $4.34M, a 46.95% decline year-over-year.
- DocGo Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $13.14M, a 35.61% decline from fiscal 2023.
- DocGo Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $20.40M, a 184.01% increase from fiscal 2022.
- DocGo Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $7.18M, a 421.96% increase from fiscal 2021.
- DocGo Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $1.38M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.51M derived: 10-K 12 month − 3 quarters · filed 2025-02-27 | $6.38M derived: sum of 2 quarters · filed 2025-02-27 | $8.80M derived: sum of 3 quarters · filed 2025-02-27 | $13.14M 10-K · filed 2025-02-27 |
| 2024-09-30 | $2.87M 10-Q · filed 2024-11-07 | $5.29M derived: sum of 2 quarters · filed 2024-11-07 | $9.63M derived: sum of 3 quarters · filed 2024-11-07 | |
| 2024-06-30 | $2.42M 10-Q · filed 2024-11-07 | $6.76M derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2024-03-31 | $4.34M 10-Q · filed 2024-11-07 | |||
| 2023-12-31 | $20.40M 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $3.34M 10-Q · filed 2024-11-07 | |||
| 2023-03-31 | $8.18M 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $7.18M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $1.02M 10-Q · filed 2023-11-06 | $3.02M derived: sum of 2 quarters · filed 2023-11-06 | $4.44M derived: sum of 3 quarters · filed 2023-11-06 | |
| 2022-06-30 | $2.00M 10-Q · filed 2023-11-06 | $3.42M derived: sum of 2 quarters · filed 2023-11-06 | ||
| 2022-03-31 | $1.42M 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | $1.38M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |